This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

11 Biotech Stocks Loved or Hated by Hedge Funds

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amarin (AMRN - Get Report)

A developer of medicinal-grade fish oil for the treatment of patients with too much fat in their blood. Amarin is attracting increasing investor attention as it gets ready to submit AMR101 for FDA approval later this quarter. The company has also been mentioned as a potential takeover target.

Year to date performance: + 55%

Performance since June 30: -12%

Expo Capital Management built a new 3 million-share position in Amarin in the second quarter, while Healthcor joined the company's roster of shareholders by acquiring 2 million shares. Steven Cohen's SAC Capital added another 2.9 million shares to its existing position.

Orbimed Advisors appears to have taken advantage of the heightened interest in Amarin to lighten its stake in the company by 4.7 million shares. Hutchin Hill Capital and David Knott Partners were also sellers during the quarter.

4 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
IDIX $24.50 0.20%
AMRN $2.33 0.00%
DSCI $8.09 0.00%
KERX $11.41 0.00%
ONTY $1.74 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs